🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Cheng Chang

University of Southern California

ORCID: 0000-0001-5804-6552

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “LRP-1 receptor combines EGFR signalling and eHsp90α autocrine to support constitutive breast cancer cell motility in absence of blood supply”.

LRP-1 receptor combines EGFR signalling and eHsp90α autocrine to support constitutive breast cancer cell motility in absence of blood supply

Scientific Reports(2022)10.1038/s41598-022-16161-y

N/A

0DataRank · unranked

10 citations

Xin Tang, Daniel Mosallaei, Mei Chen, David T. Woodley, Axel H. Schönthal +2 more

Why Are There So Few FDA-Approved Therapeutics for Wound Healing?

International Journal of Molecular Sciences(2023)10.3390/ijms242015109

N/A

0DataRank · unranked

37 citations

Cheng Chang, Brandon Levian, David T. Woodley, Wei Li, Mei Chen

The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep

Cells(2023)10.3390/cells12020277

N/A

0DataRank · unranked

22 citations

Xin Tang, David T. Woodley, Mei Chen, Wei Li, Cheng Chang

Previously unrecognized and potentially consequential challenges facing Hsp90 inhibitors in cancer clinical trials

Cell Stress and Chaperones(2024)10.1016/j.cstres.2024.08.002

N/A

0DataRank · unranked

11 citations

Xin Tang, David T. Woodley, Mei Chen, Wei Li, Cheng Chang